Items where Author is "Gentilini, Arianna"
Number of items: 9.
Rare disease policy in high-income countries:an overview of achievements, challenges, and solutions. (2025)
Gentilini, Arianna; Neez, Emilie; Wong-Rieger, Durhane
picture_as_pdf
Expanding access to NCD services via community retail pharmacies in LMICs:a systematic review of the literature. (2025)
Gentilini, Arianna; Kasonde, Lombe; Babar, Zaheer-Ud-Din
picture_as_pdf
Clinical benefit, reimbursement outcomes, and prices of FDA-approved cancer drugs reviewed through Project Orbis in the USA, Canada, England, and Scotland:a retrospective, comparative analysis. (2024)
Jenei, Kristina; Gentilini, Arianna; Haslam, Alyson; Prasad, Vinay
picture_as_pdf
The role of patient organizations on research and development:evidence from rare diseases. (2023)
Gentilini, Arianna; Miraldo, Marisa
picture_as_pdf
Industry funding of patient organisations in the UK:a retrospective study of commercial determinants, funding concentration and disease prevalence. (2023)
Gentilini, Arianna; Parvanova, Iva
picture_as_pdf
Development of policies to increase headroom for innovation in Egypt and the Kingdom of Saudi Arabia.
Kamphuis, Bregtje; Fontrier, Anna-Maria; Haig, Madeleine; Politopoulou, Konstantina; Salyga, Hana; Gentilini, Arianna; Kanavos, Panos
picture_as_pdf
How are patient inputs considered in HTA? A thematic document analysis of NICE ultra-rare disease appraisals.
Gentilini, Arianna; Rana, Alina
picture_as_pdf
Managing experts’ conflicts of interest in the EU joint clinical assessment.
Gentilini, Arianna; Parvanonva, Iva
picture_as_pdf
Safeguarding NICE from patient groups' conflicts of interest.
Parvanova, Iva; Gentilini, Arianna; Cushing, Jonathan; Naci, Huseyin